Jiang, Yuyan https://orcid.org/0000-0002-8280-6846
Cao, Hongbin
Deng, Huaping
Guan, Li
Langthasa, Jimpi https://orcid.org/0000-0002-7675-2458
Colburg, Deana Rae Crystal https://orcid.org/0000-0002-8287-9455
Melemenidis, Stavros
Cotton, Renee M.
Aleman, John https://orcid.org/0000-0002-1691-6262
Wang, Xiao-Jing https://orcid.org/0000-0001-8695-7361
Graves, Edward E.
Kalbasi, Anusha
Pu, Kanyi https://orcid.org/0000-0002-8064-6009
Rao, Jianghong https://orcid.org/0000-0002-5143-9529
Le, Quynh-Thu https://orcid.org/0000-0002-3682-1439
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01CA257907, P01CA257907)
U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (R01DE029672)
Article History
Received: 1 February 2024
Accepted: 24 September 2024
First Online: 24 October 2024
Competing interests
: Y.J. and Q.-T.L. are named inventors on a patent application related to the metabolizable supraclusters and their use in cancer treatments, which are described in this work. The other authors declare no competing interests.